Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease primarily affecting the axial skeleton. Recent research has shed light on a concerning association between AS and venous thromboembolic disease (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE). This paper explores the emerging evidence elucidating the heightened risk of VTE in patients with AS, emphasizing the underlying mechanisms and clinical implications. Factors such as chronic inflammation, endothelial dysfunction, and immobility contribute to the prothrombotic state observed in AS patients. Understanding this association is crucial for timely recognition, risk stratification, and implementation of preventive measures in clinical practice.

Ankylosing spondylitis, Venous thromboembolic disease, Deep vein thrombosis

Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees. Thromb Res 2015; 135:50- 7.

Comparison of Venous Thromboembolism after Total Hip Arthroplasty between Ankylosing Spondylitis and Osteoarthritis Dongquan Shi,1,2 Xingquan Xu,1,2 Kai Song,1,2 Zhihong Xu,1,2 Jin Dai,1,2 Dongyang Chen,1,2 and Qing Jiang1,2

Ankylosing spondylitis and risk of venous thromboembolism: A systematic review and meta- analysis. Patompong Ungprasert , Narat Srivali, Wonngarm Kittanamongkolchai Division of Rheumatology, Mayo Clinic, Division of Pulmonology and Critical Care Medicine, Mayo Clinic, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA, Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, iriraj Hospital, Mahidol University, Bangkok, Thailand

Successful Catheter-Directed Venous Thrombolysis in an Ankylosing Spondylitis Patient with Phlegmasia Cerulea Dolens Hadi Rokni Yazdi 1, *, Nematollah Rostami 2, Homa Hakimian 2, Mehdi Mohammadifar 1, Mahsa Ghajarzadeh Department of Radiology, Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran 2 Department of Internal Medicine, Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3Brain and Spinal Injury Research Center (BASIR), Tehran University of Medical Sciences, Tehran, Iran

Tung CS, Soliman PT, Wallace MJ, Wolf JK, Bodurka DC. Successful catheter-directed venous thrombolysis in phlegmasia cerulea dolens. Gynecol Oncol.2007;107(1):140-2

Lord RS, Chen FC, Devine TJ, Benn IV. Surgical treatment of acute deep venous thrombosis. World J Surg.1990; 14(5): 694-702

Manninen H, Juutilainen A, Kaukanen E, Lehto S. Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: a prospective trial with venographic and clinical follow-up. Eur J Radiol.2012; 81(6): 1197-202

Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology.1994; 191(2): 487-94

Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labro, Poulos N, Haughton SH. Catheter- directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology.1999; 211(1): 39-49

Patel NH, Plorde JJ, Meissner M. Catheter-directed thrombolysis in the treatment of phlegmasia cerulea dolens. Ann Vasc Surg.1998;12(5):471-5

Casey ET, Murad MH, Zumaeta-Garcia M, Elamin MB, Shi Q , Erwin PJ, et al. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg.2012;55(5):1463-73